Different DNA and RNA aptamers and their modified analogs have been generated against protein biomarkers related to rheumatic diseases, from general markers such as C-reactive protein, TNFα, interleukins, and their receptors, to more specific proteins such as members of the WNT signaling pathway. Here, CRP is linked to rheumatic disorder.